Alderwood Bioanalysis, Alderley Park
A laboratory built for method development not commodity assays.

Dr. Katherine Sorrell, Managing Director & Head of Bioanalysis
A scientific buyer wants a datasheet. So that's what we publish.
Alderwood Bioanalysis was founded in 2012 on the Alderley Park bioscience campus by Dr. Katherine Sorrell, previously a study director at a large contract research organisation, to run a bioanalytical laboratory sized for genuine method development rather than high-volume commodity assay work.
We're a member of the MHRA's GLP Compliance Programme and hold UKAS accreditation to ISO/IEC 17025 for the analytical methods within our scope. Method validation follows ICH M10 (2022), the current harmonised bioanalytical method validation guideline adopted by MHRA, EMA and FDA, which replaced the previously separate agency-specific guidances.
Every study runs under a quality management system built on ALCOA+ data integrity principles, a 21 CFR Part 11-compliant LIMS with full audit trail, and a QA unit that reports independently of the study director and study conduct team, not a QA function that sits inside the same reporting line as the science.
- MHRA GLP Compliance Programme member
- UKAS accredited to ISO/IEC 17025
- Method validation to ICH M10 (2022)
- QA unit independent of study conduct

Quality assurance
QA reports outside the science
Our QA unit reports to the Managing Director, entirely outside the study director and analytical team's line management, in line with GLP principles. QA audits protocol, raw data and the final report at defined milestones and can raise a finding without needing sign-off from the study team.
Managing Director & Head of Bioanalysis
|-- Study director
| `-- Analytical team [study conduct]
`-- QA unit [independent line]
|-- audit: protocol
|-- audit: raw data
`-- audit: final reportIn numbers
- Years running GLP bioanalytical studies
- 13
- Validated bioanalytical methods on file
- 340+
- Typical turnaround, working days, from sample receipt
- 15
- Studies with QA unit independent of conduct
- 100%
Lifecycle
Five stages
- 01
Feasibility & scoping
We assess the analyte, matrix and regulatory context before quoting a method development or validation scope.
- 02
Method development
A bespoke or platform method is developed and pre-validated against ICH M10 criteria.
- 03
Full validation
Full method validation is completed and a validation report issued ahead of sample analysis.
- 04
Sample analysis
Study samples are analysed against the validated method, tracked against the agreed turnaround.
- 05
QA audit & reporting
The independent QA unit audits protocol, raw data and final report before issue to the sponsor.
Accreditations
Inspected, accredited, licensed
- MHRA GLP Compliance Programme Member
- A member of the MHRA UK GLP Compliance Programme, subject to periodic inspection against the OECD Principles of Good Laboratory Practice.
- UKAS Accredited to ISO/IEC 17025
- Accredited by the United Kingdom Accreditation Service (UKAS) to ISO/IEC 17025 for the bioanalytical methods within our current scope of accreditation.
- ISO 9001 Certified
- Quality management certified to ISO 9001 across laboratory operations, independent of the ISO/IEC 17025 technical accreditation.
- Home Office Controlled Drugs Licence
- Holds a Home Office Controlled Drugs Licence for the handling of Schedule 2-5 substances encountered in bioanalytical sample work.
- ICO Registered
- Registered with the Information Commissioner's Office for the handling of study data under UK GDPR.